Diving into the world of virology, we’re thrilled to speak with Ivan Kairatov, a renowned biopharma
In the rapidly advancing world of biotechnology and medicine, protein engineering stands as a
Imagine a world where a doctor’s visit is just a click away, no matter where a patient resides or what time of day it is—telehealth has turned this vision into reality for millions across the globe, reshaping how medical services are accessed. This transformative approach breaks down barriers of
In a world where breast cancer claims countless lives each year, a staggering statistic emerges: over 70% of cases are estrogen receptor-positive (ER+), making them particularly challenging to treat due to their ability to adapt and resist therapies. Imagine a microscopic battlefield within the
In a world where humanity faces pressing challenges like sustainable energy and life-threatening
In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has
The landscape of rare disease drug development is littered with clinical failures. For every success, countless promising compounds fail to demonstrate efficacy in late-stage trials, often due to the…
Major policy changes are colliding with the complex economics of drug development. For B2B
Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is
For decades, the commercial spotlight in biopharma has shone the brightest on high-prevalence
Misdiagnosis is a problem facing medicine today. A significant reason for this challenge is that
I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with a profound understanding of technology and innovation in the healthcare industry. With a robust background in research and development, Ivan has been at the forefront of exploring how artificial intelligence can transform
In a world where neurological disorders affect millions globally, the urgency for faster, more
Japan stands at the forefront of a digital transformation that is reshaping the very foundation of
